Ann: Paradigm AGM Presentation, page-27

My concern I wanted answered in this AGM was that without Marco they wouldn't have the deal making prowess to get a good deal for owners. That was quickly put to bed with the Plexus and Angel consultancies. The process seems good. I also had a chat with Paul afterwards about safety issues. Specifically I wanted to know about incidence of thrombocytopenia and retinitis pigmentosa that have both been seen with PPS in past. He indicated that both are being specifically monitored in the trial but that to date they have not had a single case of either in recipients. A big tick for safety profile.